Benefits of ICU admission for patients with acute respiratory failure or sepsis: A mixed-methods study across 26 hospitals

急性呼吸衰竭或败血症患者入住 ICU 的好处:一项跨 26 家医院的混合方法研究

基本信息

  • 批准号:
    9286563
  • 负责人:
  • 金额:
    $ 73.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-04-01 至 2021-03-31
  • 项目状态:
    已结题

项目摘要

Patients with acute respiratory failure (ARF) and sepsis (the most common and lethal cause of the acute respiratory distress syndrome) are commonly admitted to intensive care units (ICUs) in the United States even when they do not require life support. However, ICU admission rates for these patients vary considerably among hospitals and even within hospitals over time due to bed availability. This practice variability suggests that some patients may be “under-triaged” to wards when their outcomes could be improved by sending them directly to the ICU (e.g., due to closer nurse or respiratory therapist monitoring). Other patients may be “over- triaged” to ICUs when their outcomes and costs of care would be as good or better by sending them directly to wards (e.g., due to less delirium or immobility). Furthermore, determining which of these “discretionary” ICU admissions could be treated as well or better on wards would improve timely access to ICUs for patients with more advanced forms of cardiorespiratory collapse and more obvious indications for ICU admission. To improve outcomes for patients with ARF and/or sepsis by optimizing their triage, this application proposes a mixed-methods study of patients admitted through the emergency departments of 26 diverse hospitals in the Kaiser Permanente Northern California health system and the University of Pennsylvania Health System. Our primary goals are to determine which patients with ARF and/or sepsis benefit from ICU admission, and which emergency department, ward, and ICU characteristics and processes of care contribute to such net ICU benefits. Several methodological innovations will enable us to achieve these goals, and to surmount key limitations to prior studies that have sought to determine which acutely ill patients benefit from ICU admission. First, whereas all prior studies used approaches to causal inference that were susceptible to confounding by unmeasured differences among hospitals, we will obtain unbiased estimates of which patients benefit from ICU or ward admission by modeling a within-hospital variable – ICU capacity at the time of triage – as an instrumental variable. Second, although prior studies have been unable to determine exactly which patients the results apply to, the granular electronic health record data available across our study hospitals will enable our results to apply directly to well-characterized individual patients, promoting personalized triage decisions. Third, our use of ethnography and semi-structured interviews in hospitals that obtain large and small net ICU benefits will identify mechanisms by which different hospitals achieve improved outcomes in ICUs and wards. Completing the aims of this study will improve public health by identifying ways in which emergency departments, ICUs, and wards can improve outcomes for the more than 4 million Americans hospitalized each year with ARF and/or sepsis. Such results will also provide the evidence needed to develop and test triage algorithms to improve outcomes for patients with ARF and/or sepsis presenting to emergency departments.
患者并发急性呼吸衰竭(ARF)和脓毒症(最常见和致命的急性病因)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott D Halpern其他文献

The future of the orthopaedic clinician-scientist: part II: Identification of factors that may influence orthopaedic residents' intent to perform research.
骨科临床医生科学家的未来:第二部分:确定可能影响骨科住院医师开展研究意图的因素。
Rebuttal From Dr Halpern
  • DOI:
    10.1378/chest.14-1586
  • 发表时间:
    2014-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Scott D Halpern
  • 通讯作者:
    Scott D Halpern

Scott D Halpern的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott D Halpern', 18)}}的其他基金

Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
  • 批准号:
    10734357
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Transforming residential palliative care for persons with dementia through behavioral economics and data science
通过行为经济学和数据科学改变痴呆症患者的住院姑息治疗
  • 批准号:
    10474380
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Transforming residential palliative care for persons with dementia through behavioral economics and data science
通过行为经济学和数据科学改变痴呆症患者的住院姑息治疗
  • 批准号:
    10017845
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Transforming residential palliative care for persons with dementia through behavioral economics and data science
通过行为经济学和数据科学改变痴呆症患者的住院姑息治疗
  • 批准号:
    10251982
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10474381
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10657603
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10251983
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    9810434
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Transforming residential palliative care for persons with dementia through behavioral economics and data science
通过行为经济学和数据科学改变痴呆症患者的住院姑息治疗
  • 批准号:
    10657602
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:
Admin-Core
管理核心
  • 批准号:
    10017884
  • 财政年份:
    2019
  • 资助金额:
    $ 73.45万
  • 项目类别:

相似海外基金

Novel Digital Methods to Evaluate Functional and Pulmonary Outcomes following Pediatric Acute Respiratory Failure
评估小儿急性呼吸衰竭后功能和肺部结果的新型数字方法
  • 批准号:
    10724042
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Optimizing Time-Limited Trials of Mechanical Ventilation in Acute Respiratory Failure: A Mixed Methods Observational Study
优化急性呼吸衰竭机械通气的限时试验:混合方法观察研究
  • 批准号:
    10633823
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Use of Inter-Hospital Transfer Services in Critical Illness and Acute Respiratory Failure
在危重疾病和急性呼吸衰竭中使用医院间转运服务
  • 批准号:
    10739060
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Strengthening implementation science in Acute Respiratory Failure using multilevel analysis of existing data
利用现有数据的多级分析加强急性呼吸衰竭的实施科学
  • 批准号:
    10731311
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Identifying patient subgroups and processes of care that cause outcome differences following ICU vs. ward triage among patients with acute respiratory failure and sepsis
确定急性呼吸衰竭和脓毒症患者在 ICU 与病房分诊后导致结局差异的患者亚组和护理流程
  • 批准号:
    10734357
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Respiratory Drive in Acute Respiratory Failure
急性呼吸衰竭中的呼吸驱动
  • 批准号:
    10637245
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Temporal trends in quality indicators of palliative care for patients with chronic illness hospitalized with acute respiratory failure
因急性呼吸衰竭住院的慢性病患者姑息治疗质量指标的时间趋势
  • 批准号:
    10622756
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Health expectations after acute respiratory failure in survivor-care partner dyads
幸存者护理伙伴二人组急性呼吸衰竭后的健康期望
  • 批准号:
    10732929
  • 财政年份:
    2023
  • 资助金额:
    $ 73.45万
  • 项目类别:
Association of patient characteristics and antibiotic timing with the development of acute respiratory failure in hospital-acquired sepsis
患者特征和抗生素使用时机与医院获得性脓毒症急性呼吸衰竭发展的关系
  • 批准号:
    10313769
  • 财政年份:
    2022
  • 资助金额:
    $ 73.45万
  • 项目类别:
Financial Hardship among Patients with Acute Respiratory Failure and their Family Member Caregivers: Understanding the Impact on Patient- and Family- Centered Outcomes
急性呼吸衰竭患者及其家庭成员护理人员的经济困难:了解对以患者和家庭为中心的结果的影响
  • 批准号:
    10413457
  • 财政年份:
    2022
  • 资助金额:
    $ 73.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了